Clinical trials in follicular lymphoma

The list below shows  The Lymphoma Group's current clinical trials open for recruitment for follicular lymphoma patients.

If you would like to know how to access our trials, please see how to contact us.

• GEN3013 - Phase 1/2 study using antibody GEN3013 to target CD20- expressing cells in patients with B cell non-Hodgkin lymphoma
  
  Suitable for patients with B cell non-Hodgkin lymphoma which has come back after previous treatment
  

• PETReA - A phase 3 trial testing whether PET scans can help make treatment decisions for people with follicular lymphoma
  
  Suitable for patients who haven't yet received any treatment
  

• GO29781 - A phase 1/1b trial testing mosunetuzumab, on its own or with atezolizumab.
  
  Suitable for patients with lymphoma which has come back after previous treatment
  
  

• GCT3013-02 - A phase 1b/2 trial of a targeted treatment, epcoritamab, in combination with different chemotherapy regimens, in people with B-cell non-Hodgkin lymphoma.
  
  

• CO41942 - A phase 1b trial testing different combinations of targeted drugs in people with relapsed or refractory follicular lymphoma.
  
  
• JNJLYM1001 - A phase 1 trial of a new treatment called JNJ-75348780 in people with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia.
  
  

• CCS1477-02 - A phase 1/2a study of CCS1477 in blood cancers, including relapsed or refractory non-Hodgkin lymphoma.
  
  

With special thanks to the following: